Biotech Trade Shows:
Stamina, Me-too, or Failures

A View From Deutsche Messe's Biotechnica 2009

October 2009. Platforms for biotech industries in the United States and Europe fall quite apart, but needs to internationalise are the same on both sides of the Atlantic. While major American private organisers of biotech trade shows and conferences (e.g. Reed, Cambridge Healthtech Institute, Technology Vision Group, IBC USA Conferences / Informa) are looking for expansion, those in Europe (e.g. Deutsche Messe / DMAG, GL Events, Leipziger Messe) are rather building capacities in Asia than the States.

On the occasion of Biotechnica Hannover, B2Bioworld is closely looking at DMAG’s strategy, major European biotech trade shows, and their pricing schemes.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 3 pages

Full Company License enquire here

Back to section

Related Editorial Articles

Organising the exhibition and trade fair industry globally
Andreas Gruchow, President of Union des Foires International 2017 on to-do’s, challenges, and strategy

Riding ahead demand in the trade fair industry
Jochen Köckler of Deutsche Messe AG about strategic assumptions and business in different parts of the world

Bio-Based Economy? What’s in it for Business
An industry perspective and key trends in an emerging lead market

Being the Truffle Pig of Industries Worldwide
Stephan Ph. Kühne, former Member of the Board on Deutsche Messe’s strategies to increase profitability and outperform competition on a global scale

How to Ensure the Health of the Industry
Paul Pomerantz on strategic re-orientation of DIA, the world’s largest organisation of pharma professionals, tthe Drug Information Association (DIA)

BIO 2009 failed to mirror biotechnology markets worldwide